- ►adisonline.com [PDF] R Oiknine, M Bernbaum, AD Mooradian - Drugs, 2005 - pt.wkhealth.com Insulin is one of the oldest and best studied treatments for diabetes mellitus.
Despite many improvements in the management of diabetes, the nonphysiological
time-action profiles of conventional insulins remain a significant ... Cited by 59 - Related articles - All 5 versions
- ►diabetesjournals.org T Danne, RHA Becker, T Heise, C Bittner, AD … - Diabetes Care, 2005 - Am Diabetes Assoc RESULTS—For insulin glulisine versus RHI, maximum insulin concentrations (58
vs. 33 μIU/ml, P < 0.05) and initial insulin concentrations (insulin [area
under the curve] AUC 0–2h 5,232 vs. 2,994 μIU · min −1 · ml −1 , P ... Cited by 46 - Related articles - BL Direct - All 7 versions
FJ Gómez-Pérez, JA Rull - Archives of medical research, 2005 - Elsevier In normal humans, blood glucose and insulin are maintained within a narrow range
despite wide variations in physical activity and dietary intake. At present,
reproducing this pattern is an impossible task in type 1 diabetes and ... Cited by 25 - Related articles - All 12 versions
- ►fetalneonatal.com T Danne, K Lange, O Kordonouri - Archives of Disease in Childhood, 2007 - adc.bmjjournals.com.p.angrylapdog.com Both type 1 and type 2 diabetes can occur in children and adolescents. Of the
230 million people affected by diabetes worldwide, 4.9 million have type 1
diabetes. Type 1 diabetes is the most common chronic disease in children in ... Cited by 12 - Related articles - BL Direct - All 5 versions
SS Braithwaite - Seminars in thoracic and cardiovascular surgery, 2006 - Elsevier After cardiac surgery, it is medical mismanagement to place an order for sliding
scale insulin at the time of transitioning from intravenous insulin. Use of
basal-prandial-correction therapy with insulin analogs constitutes a ... Cited by 11 - Related articles - All 12 versions
L Meneghini - Southern Medical Journal, 2007 - journals.lww.com Dr. Meneghini has received research support from Amylin, Merck, Novo Nordisk,
and Sanofi-Aventis. He is on an advisory panel for NIPRO Systems and holds stock
in Amylin. He belongs to the Speakers' Bureaus for Amylin, Eli Lilly, Glaxo ... Cited by 11 - Related articles - BL Direct - All 7 versions
AK Steck, GJ Klingensmith, R Fiallo-Scharer - Pediatric Diabetes, 2007 - interscience.wiley.com Abstract: Since the findings of the Diabetes Control and Complications Trial
became public in 1993, intensive insulin therapy has been recommended for all
children. However, successful implementation remains a challenge because of ... Cited by 7 - Related articles - BL Direct - All 3 versions
T Danne, J Rastam, R Odendahl, A Nake, U … - Pediatric diabetes, 2007 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 6 - Related articles - BL Direct - All 4 versions
AB King, DU Armstrong - Current Diabetes Reviews, 2005 - ingentaconnect.com Abstract: Basal bolus insulin dosing (BBD) may be defined as the physiological
replacement of basal and bolus insulin to achieve near normal glycemia without
hypoglycemia and loss of life quality. Normally, continuous and variable ... Cited by 5 - Related articles - BL Direct - All 2 versions
